Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-arm study of temozolomide in combination with topotecan in paediatric solid tumours
2009-012644-16Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2009
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide and topotecan in neuroblastoma, brain neoplasm and solid neoplasms, sponsored by Policlinico Gemelli. Primary endpoint: Objective response rate. Started May 2009; status: completed.
02
Drugs
temozolomidetopotecan
03
Conditions
neuroblastomabrain neoplasmsolid neoplasms
Beyond the preview
Go deeper on 2009-012644-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012644-16.